Non-alcoholic fatty liver disease assessment in Nepal
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20161645Keywords:
Biomarkers, Body mass index, Non-alcoholic fatty liver disease, UltrasonographyAbstract
Background: Non-alcoholic fatty liver disease (NAFLD) is a common entity seen in routine ultrasonography of the patients. The study also aims to demonstrate its relationship with biochemical markers and anthropometric measurement.
Methods: It was a retrospective observational study of the patients who had come for general health check-up where routine clinical history and examination, ultrasound of the abdomen and biochemical tests for liver function and lipid profile were performed. Exclusion made in the study includes alcoholic patients and other secondary causes of the fatty changes in the liver. Ultrasound staging was done for control (no steatosis), mild, moderate and severe fatty changes of the liver. Software named SPSS Statistics version 16.0 used for the proforma and analysis of data.
Results: In a total of ninety-nine patients, NAFLD was seen higher in women with 57.1%. The mild fatty liver was observed in 55.1%, moderate fatty liver in 32.7% and severe fatty liver in 12.2% of the patients. There were significantly higher triglycerides (TG) and alanine aminotransferase (ALT) levels as the severity of fatty liver increased. Cholesterol high density lipoprotein (HDL) was significantly lower as the severity of fatty liver increased. When compared to normal counterparts, overweight and obese patients had 4.2 and 5.1 times increased the risk of having NAFLD. Elevated ALT (OR=2.5, CI=1.8-3.6), triglyceride (OR=2.3, CI=1.6-3.4) and very low density lipoprotein (VLDL) (OR=1.6, CI=1.1-2.3) levels were associated with NAFLD.
Conclusions: Increased body mass index had more risk of having non-alcoholic fatty liver disease. HDL significantly decreased as the severity of fatty liver increased. ALT, TG, and VLDL concentrations showed strong association of being raised in non-alcoholic fatty liver disease patients.Metrics
References
Neuschwander‐Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003;37(5):1202-19.
Abangah G, Yousefi A, Asadollahi R, Veisani Y, Rahimifar P, Alizadeh S. Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease. Iranian Red Crescent Medical Journal. 2014;16(1).
Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology. 1999;116(6):1413-9.
Duvnjak M, Lerotić I, Barsić N, Tomasić V, Virović Jukić L, Velagić V. Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol. 2007;13(34):4539-50.
Niaz A, Ali Z, Nayyar S, Fatima N. Prevalence of NAFLD in Healthy and Young Male Individuals. ISRN Gastroenterology. 2011;2011:4.
Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29(3):664-9.
Babalı A, Çakal E, Purnak T, Bıyıkoğlu İ, Çakal B, Yüksel O, et al. Serum α-fetoprotein levels in liver steatosis. Hepatology International. 2009;3(4):551-5.
Bastati N, Feier D, Wibmer A, Traussnigg S, Balassy C, Tamandl D, et al. Noninvasive Differentiation of Simple Steatosis and Steatohepatitis by Using Gadoxetic Acid–enhanced MR Imaging in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study. Radiology. 2014;271(3):739-47.
Ghamar-Chehreh ME, Khedmat H, Amini M, Taheri S. Predictive Factors for Ultrasonographic Grading of Nonalcoholic Fatty Liver Disease. Hepat Mon. 2012;12(11):e6860.
Garcia-Monzón C, Martín-Pérez E, Iacono OL, Fernández-Bermejo M, Majano PL, Apolinario A, et al. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. Journal of Hepatology. 2000;33(5):716-24.
Koot BGP, van der Baan-Slootweg OH, Tamminga-Smeulders CLJ, Rijcken THP, Korevaar JC, van Aalderen WM, et al. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement. Archives of Disease in Childhood. 2011;96(7):669-74.
Tarantino G, Conca P, Riccio A, Tarantino M, Di Minno MN, Chianese D, et al. Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign? Journal of Translational Medicine. 2008;6(1):1-8.
Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A. MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Pædiatrica. 2007;96(4):542-7.
Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123(3):745-50.
Yates C, Streight R. Focal fatty infiltration of the liver simulating metastatic disease. Radiology. 1986;159(1):83-4.
Rumack CM, Wilson SR, Charboneau JW, Levine D. CHAPTER 4: The Liver. Diagnostic Ultrasound. 4 ed: Elsevier/Mosby; 2011. p. 95-7.
Kotronen A, Yki-Järvinen H, Männistö S, Saarikoski L, Korpi-Hyövälti E, Oksa H, et al. Non-alcoholic and alcoholic fatty liver disease-two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey. BMC Public Health. 2010;10(1):1.
Kundrotas LW, Clement DJ. Serum alanine aminotransferase (ALT) elevation in asymptomatic US air force basic trainee blood donors. Digestive Diseases and Sciences. 1993;38(12):2145-50.
Manninen V, Tenkanen L, Koskinen P, Huttunen J, Mänttäri M, Heinonen O, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation. 1992;85(1):37-45.
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106(25):3143.
Wilson S, Rosen I, Chin-Sang H, Arenson A. Fatty infiltration of the liver--an imaging challenge. Journal of the Canadian Association of Radiologists. 1982;33(4):227-32.
O'Leary CM. Fetal alcohol syndrome: diagnosis, epidemiology, and developmental outcomes. Journal of paediatrics and child health. 2004;40(1‐2):2-7.
Little JF, Hepper PG, Dornan JC. Maternal alcohol consumption during pregnancy and fetal startle behaviour. Physiology & Behavior. 2002;76(4–5):691-4.
Razavizade M, Jamali R, Arj A, Talari H. Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International. 2012;11(5):513-20.
Fu C-C, Chen M-C, Li Y-M, Liu T-T, Wang L-Y. The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents. Annals Academy of Medicine Singapore. 2009;38(1):15-7.
Chan D, Li A, Chu W, Chan M, Wong E, Liu E, et al. Hepatic steatosis in obese Chinese children. International journal of obesity. 2004;28(10):1257-63.
Hsiao T, Chen J, Wang J. Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients. International journal of obesity. 2004;28(1):167-72.
Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Annals of internal medicine. 2000;132(2):112-7.
Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Alanine aminotransferase as a marker of non‐alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes/metabolism research and reviews. 2006;22(6):437-43.
30. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. Canadian Medical Association Journal. 2005;172(7):899-905.
Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology. 2005;42(5):987-1000.
Ye J, Chen Z, Wang T, Tong J, Li X, Jiang J, et al. Role of tissue disorder markers in the evaluation of disease progress and outcome prediction: a prospective cohort study in non‐cardiac critically ill patients. Journal of clinical laboratory analysis. 2010;24(6):376-84.
Lee SS, Park SH, Kim HJ, Kim SY, Kim M-Y, Kim DY, et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. Journal of hepatology. 2010;52(4):579-85.
Downloads
Published
How to Cite
Issue
Section
